Pre-order Enquiry
Request Free Sample
Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14143376 | Publishing Date : 25-Apr-2019 | No. of pages : 100
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Medications Therapeutics
1.4.3 Medical Devices Therapeutics
1.5 Market by Application
1.5.1 Global Parkinson's Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Under 40 Years Old
1.5.3 40-65 Years Old
1.5.4 Above 65 Years Old
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Parkinson's Disease Therapeutics Market Size
2.2 Parkinson's Disease Therapeutics Growth Trends by Regions
2.2.1 Parkinson's Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Parkinson's Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Parkinson's Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Parkinson's Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Parkinson's Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Parkinson's Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Parkinson's Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Parkinson's Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Parkinson's Disease Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Parkinson's Disease Therapeutics Market Size (2014-2019)
5.2 Parkinson's Disease Therapeutics Key Players in United States
5.3 United States Parkinson's Disease Therapeutics Market Size by Type
5.4 United States Parkinson's Disease Therapeutics Market Size by Application
6 Europe
6.1 Europe Parkinson's Disease Therapeutics Market Size (2014-2019)
6.2 Parkinson's Disease Therapeutics Key Players in Europe
6.3 Europe Parkinson's Disease Therapeutics Market Size by Type
6.4 Europe Parkinson's Disease Therapeutics Market Size by Application
7 China
7.1 China Parkinson's Disease Therapeutics Market Size (2014-2019)
7.2 Parkinson's Disease Therapeutics Key Players in China
7.3 China Parkinson's Disease Therapeutics Market Size by Type
7.4 China Parkinson's Disease Therapeutics Market Size by Application
8 Japan
8.1 Japan Parkinson's Disease Therapeutics Market Size (2014-2019)
8.2 Parkinson's Disease Therapeutics Key Players in Japan
8.3 Japan Parkinson's Disease Therapeutics Market Size by Type
8.4 Japan Parkinson's Disease Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2014-2019)
9.2 Parkinson's Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type
9.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application
10 India
10.1 India Parkinson's Disease Therapeutics Market Size (2014-2019)
10.2 Parkinson's Disease Therapeutics Key Players in India
10.3 India Parkinson's Disease Therapeutics Market Size by Type
10.4 India Parkinson's Disease Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Parkinson's Disease Therapeutics Market Size (2014-2019)
11.2 Parkinson's Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Parkinson's Disease Therapeutics Market Size by Type
11.4 Central & South America Parkinson's Disease Therapeutics Market Size by Application
12 International Players Profiles
12.1 GSK
12.1.1 GSK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Parkinson's Disease Therapeutics Introduction
12.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.1.5 GSK Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Parkinson's Disease Therapeutics Introduction
12.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 Parkinson's Disease Therapeutics Introduction
12.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Teva Pharmaceutical
12.4.1 Teva Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Parkinson's Disease Therapeutics Introduction
12.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.4.5 Teva Pharmaceutical Recent Development
12.5 Abbvie
12.5.1 Abbvie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Parkinson's Disease Therapeutics Introduction
12.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.5.5 Abbvie Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Parkinson's Disease Therapeutics Introduction
12.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.6.5 Merck Recent Development
12.7 Akorn
12.7.1 Akorn Company Details
12.7.2 Company Description and Business Overview
12.7.3 Parkinson's Disease Therapeutics Introduction
12.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.7.5 Akorn Recent Development
12.8 Kyowa Hakko Kirin Pharma
12.8.1 Kyowa Hakko Kirin Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Parkinson's Disease Therapeutics Introduction
12.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.8.5 Kyowa Hakko Kirin Pharma Recent Development
12.9 Astellas Pharma
12.9.1 Astellas Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Parkinson's Disease Therapeutics Introduction
12.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.9.5 Astellas Pharma Recent Development
12.10 Desitin Arzneimittel
12.10.1 Desitin Arzneimittel Company Details
12.10.2 Company Description and Business Overview
12.10.3 Parkinson's Disease Therapeutics Introduction
12.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.10.5 Desitin Arzneimittel Recent Development
12.11 Endo Pharmaceuticals
12.12 F.Hoffmann-La Roche
12.13 H.Lundbeck
12.14 Valeant
12.15 Apokyn
12.16 Orion
12.17 Stada Arzneimittel
12.18 US WorldMeds
12.19 Valeant Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Parkinson's Disease Therapeutics Key Market Segments
Table Key Players Parkinson's Disease Therapeutics Covered
Table Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Type 2014-2025
Figure Medications Therapeutics Figures
Table Key Players of Medications Therapeutics
Figure Medical Devices Therapeutics Figures
Table Key Players of Medical Devices Therapeutics
Table Global Parkinson's Disease Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Under 40 Years Old Case Studies
Figure 40-65 Years Old Case Studies
Figure Above 65 Years Old Case Studies
Figure Parkinson's Disease Therapeutics Report Years Considered
Table Global Parkinson's Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Parkinson's Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Parkinson's Disease Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Parkinson's Disease Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Parkinson's Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Parkinson's Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Parkinson's Disease Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Share by Manufacturers in 2018
Table Global Parkinson's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Parkinson's Disease Therapeutics Product/Solution/Service
Table Date of Enter into Parkinson's Disease Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Parkinson's Disease Therapeutics Market Size Share by Type (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Parkinson's Disease Therapeutics Market Size Share by Application (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Parkinson's Disease Therapeutics Revenue Market Share by Application in 2018
Figure United States Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table United States Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table United States Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure Europe Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table Europe Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table Europe Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure China Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table China Parkinson's Disease Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table China Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure Japan Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table Japan Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table Japan Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure India Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table India Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table India Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table Central & South America Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table Central & South America Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Table GSK Company Details
Table GSK Revenue in Parkinson's Disease Therapeutics Business (2014-2019) (Million US$)
Figure GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Abbvie Recent Development
Table Merck Company Details
Table Merck Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Akorn Company Details
Table Akorn Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Akorn Recent Development
Table Kyowa Hakko Kirin Pharma Company Details
Table Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Kyowa Hakko Kirin Pharma Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Astellas Pharma Recent Development
Table Desitin Arzneimittel Company Details
Table Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Desitin Arzneimittel Recent Development
Table Endo Pharmaceuticals Company Details
Table F.Hoffmann-La Roche Company Details
Table H.Lundbeck Company Details
Table Valeant Company Details
Table Apokyn Company Details
Table Orion Company Details
Table Stada Arzneimittel Company Details
Table US WorldMeds Company Details
Table Valeant Pharmaceuticals Company Details
Table Global Parkinson's Disease Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Parkinson's Disease Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Parkinson's Disease Therapeutics Market Size by Product (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size by Product in 2025
Table Global Parkinson's Disease Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Parkinson's Disease Therapeutics Market Size by Application (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2019-2025
GSKNovartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Merck
Akorn
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals
